Guidelines for the management of vitiligo: the European Dermatology Forum consensus
A Taieb, A Alomar, M Böhm… - British Journal of …, 2013 - academic.oup.com
The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held
back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at …
back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at …
Vitiligo puzzle: the pieces fall in place
W Westerhof, M d'Ischia - Pigment Cell Research, 2007 - Wiley Online Library
Over the years, the role of biochemical, immunological, genetic, and other biological aspects
in the pathogenesis of vitiligo has been studied. So far, no convincing model describing the …
in the pathogenesis of vitiligo has been studied. So far, no convincing model describing the …
Depigmentation therapies for normal skin in vitiligo universalis
KM AlGhamdi, A Kumar - Journal of the European Academy of …, 2011 - Wiley Online Library
If vitiligo involves most of the body, it might be easier to depigment the normal remaining
skin rather than to attempt repigmentation. We reviewed the literature to date regarding …
skin rather than to attempt repigmentation. We reviewed the literature to date regarding …
TMT-based quantitative proteomic and physiological analyses on serums of Chinese patients with active vitiligo
Z Chen, Y Li, S Nie, Z Wu - Clinical, Cosmetic and Investigational …, 2023 - Taylor & Francis
Purpose Vitiligo is an acquired depigmented skin disorder. Though genetic background,
autoimmune dysregulation, and oxidative stress were reported involved in the development …
autoimmune dysregulation, and oxidative stress were reported involved in the development …
Depigmentation therapies for vitiligo
PE Grimes, R Nashawati - Dermatologic clinics, 2017 - derm.theclinics.com
Vitiligo is a common acquired disorder of the epidermis and hair follicles that manifests
clinically as progressive depigmentation due to loss of functioning melanocytes. It affects 1 …
clinically as progressive depigmentation due to loss of functioning melanocytes. It affects 1 …
Melanocytotoxic chemicals and their toxic mechanisms
M Kim, KM Lim - Toxicological Research, 2022 - Springer
Melanocyte cell death can lead to various melanocyte-related skin diseases including
vitiligo and leukoderma. Melanocytotoxic chemicals are one of the most well-known causes …
vitiligo and leukoderma. Melanocytotoxic chemicals are one of the most well-known causes …
Multifaceted amelioration of cutaneous photoageing by (0.3%) retinol
KT Mellody, EJ Bradley, B Mambwe… - … Journal of Cosmetic …, 2022 - Wiley Online Library
Background Although retinol skin care products improve the appearance of photoaged skin,
there is a need for an effective retinol concentration that provides skin benefits without …
there is a need for an effective retinol concentration that provides skin benefits without …
[HTML][HTML] Depigmentation therapies in vitiligo
Depigmentation therapy in vitiligo is an option in those with extensive vitiligo who have
failed to respond to medical therapy and have obvious cosmetic disfigurement due to …
failed to respond to medical therapy and have obvious cosmetic disfigurement due to …
Autologously transplanted dermis‐derived cells alleviated monobenzone‐induced vitiligo in mouse
Vitiligo is a depigmentation disease which affects skin and hair follicles with a prevalence of
0.5%–1% worldwide. In this study, we aimed to investigate treatmental potential of dermis …
0.5%–1% worldwide. In this study, we aimed to investigate treatmental potential of dermis …
Vitiligo: an update on current pharmacotherapy and future directions
R Colucci, T Lotti, S Moretti - Expert opinion on pharmacotherapy, 2012 - Taylor & Francis
Introduction: Vitiligo is a common pigmentary skin disorder, characterized by the
appearance of white macules on the skin, mucosal or hair. Treatment is often a tough …
appearance of white macules on the skin, mucosal or hair. Treatment is often a tough …